CartiHeal (Israel) Announces FDA IDE Approval of its Agili-C Implant for the Treatment of Joint Surface Lesions
Israeli company CartiHeal (2009), developer of a cell-free, off-the-shelf implant for use…
Israeli company CartiHeal (2009), developer of a cell-free, off-the-shelf implant for use…
In a sign of growing ties between Israel and Africa, officials from…
A new class of biological pacemaker is promising notable advantages over traditional,…
The Medical Corps of the Israel Defense Forces (IDF) has collaborated with…
A delegation of Tel Aviv University students from The Iby and Aladar Fleischman Faculty…